Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REspiratory Syncytial Virus Consortium in EUrope (RESCEU) Study: Defining the Burden of Disease of Respiratory Syncytial Virus in Europe.

NCT03627572 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT03627572
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03627572 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REspiratory Syncytial Virus Consortium in EUrope (RESCEU) Study: Defining the Burden of Disease of Respiratory Syncytial Virus in Europe.
Lead sponsor
UMC Utrecht
Phase
Observational
Overall status
Unknown status
Start date
July 21, 2017
Completion date
December 31, 2021
Enrollment
10,000 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

respiratory syncytial virus infections, rsv bronchiolitis, rsv infection